HIMS
Hims & Hers Health, Inc.
There isn't enough reported data to score HIMS yet.
IMMP
Immutep Limited
There isn't enough reported data to score IMMP yet.
HIMS Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Weak | |
| Stable | |
| Strong |
HIMS's revenue and balance sheet are currently strong, and its cash flow is stable, but its profitability is weak.
IMMP Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Unavailable | |
| Unavailable | |
| Unavailable |
There isn't enough reported data to rate IMMP's fundamentals.
HIMS PE Valuation
HIMS has no meaningful PE right now: it lost money over the past year.
IMMP PE Valuation
IMMP has no meaningful PE right now: it lost money over the past year.
HIMS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Turning to a loss | |
| Strong growth | |
| Stable | |
| Limited | |
| Low |
Analysts expect HIMS's revenue to grow, but its earnings to decline. However, they disagree widely on these estimates.
IMMP Forward outlook
There aren't enough analyst estimates for IMMP to show an outlook.
HIMS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.83 | -257% |
| Q2 2026 | -$0.63 | -180% |
| Q1 2026 | -$0.09 | -113% |
| Q4 2025 | $0.51 | -3.8% |
| Q3 2025 | $0.53 | +20% |
| Q2 2025 | $0.79 | +888% |
| Q1 2025 | $0.68 | +$0.69 |
| Q4 2024 | $0.53 | +$0.64 |
HIMS has swung to a loss: it lost $0.83 per share over the past year, after a profit the year before.
IMMP Earnings Per Share
IMMP and HIMS do not have enough comparable growth data to identify a winner.
HIMS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $890.4M | +49% |
| Q2 2026 | $753.2M | +38% |
| Q1 2026 | $608.1M | +3.8% |
| Q4 2025 | $617.8M | +28% |
| Q3 2025 | $599M | +49% |
| Q2 2025 | $544.8M | +73% |
| Q1 2025 | $586M | +111% |
| Q4 2024 | $481.1M | +95% |
HIMS's revenue has grown year over year every quarter since late 2021: $890M last quarter, up 49% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -7.4% | -9.4 points |
| Q2 2026 | -13% | -18 points |
| Q1 2026 | -13% | -23 points |
| Q4 2025 | 1.5% | -2.4 points |
| Q3 2025 | 2% | -3.6 points |
| Q2 2025 | 4.9% | +1.4 points |
| Q1 2025 | 9.9% | +6.3 points |
| Q4 2024 | 3.9% | +4 points |
HIMS has the edge over IMMP on profitability, with a higher operating margin.
IMMP Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $7.3M | +460% |
| Q4 2025 | $4.1M | +91% |
| Q2 2025 | $1.3M | +9.5% |
| Q4 2024 | $2.2M | +49% |
| Q2 2024 | $1.2M | -4.9% |
| Q4 2023 | $1.4M | +25% |
| Q2 2023 | $1.2M | +968% |
| Q4 2022 | $1.2M | -19% |
IMMP has the edge over HIMS in the latest year-over-year revenue comparison.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -372% | +2201 points |
| Q4 2025 | -764% | +1300 points |
| Q2 2025 | -3938% | -2739 points |
| Q4 2024 | -1644% | -273 points |
| Q2 2024 | -2573% | +8847 points |
| Q4 2023 | -2064% | -1155 points |
| Q2 2023 | -1199% | -538 points |
| Q4 2022 | -1371% | -801 points |
IMMP's operating margin was −372% last quarter, up 2201 points from the same quarter a year ago.
HIMS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $26M | -67% |
| Q2 2026 | -$68.2M | +$1.3M |
| Q1 2026 | $53.1M | +5.9% |
| Q3 2025 | $79.3M | -7% |
| Q2 2025 | -$69.5M | -230% |
| Q1 2025 | $50.1M | +94% |
| Q3 2024 | $85.3M | +238% |
| Q2 2024 | $53.6M | +219% |
HIMS still generates free cash flow, though less than at its 2024 peak: $8M over the past year.
IMMP Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$20M | +$3M |
| Q4 2025 | -$19.3M | +$234.8K |
| Q2 2025 | -$23M | -$10.7M |
| Q4 2024 | -$19.5M | -$7.3M |
| Q2 2024 | -$12.2M | +$60.4K |
| Q4 2023 | -$12.2M | +$60.4K |
| Q2 2023 | -$12.3M | -$1.9M |
| Q4 2022 | -$12.3M | -$1.9M |
IMMP has burned cash in almost every quarter: −$82M over the past year, against −$49M the year before.
HIMS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.9% | +2.1M shares |
| 1 year | -6% | -14.9M shares |
| 3 years | +11% | +23.7M shares |
| 5 years | +17% | +33.8M shares |
HIMS has the edge over IMMP on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q4 2025 | $80.5M |
| Q3 2025 | $9.5M |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | $5M |
| Q3 2024 | $30M |
| Q2 2024 | $19.9M |
| Q1 2024 | $28.1M |
IMMP Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +14.6K shares |
| 1 year | +21% | +1.3M shares |
| 3 years | +242% | +5.2M shares |
| 5 years | +245% | +5.2M shares |
| Available history | +245% | +5.2M shares |
IMMP has 7M diluted shares, up 21% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2026 | — |
| Q4 2025 | — |
| Q2 2025 | — |
| Q4 2024 | — |
| Q2 2024 | — |
| Q4 2023 | — |
| Q2 2023 | — |
| Q4 2022 | — |
HIMS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2026 | -5.9x | Net Cash |
| Q4 2025 | -1.4x | Net Cash |
| Q3 2025 | -2.2x | Net Cash |
| Q2 2025 | -7.3x | Net Cash |
| Q1 2025 | -2.1x | Net Cash |
| Q4 2024 | -2.8x | Net Cash |
| Q3 2024 | -2.9x | Net Cash |
| Q2 2024 | -5.5x | Net Cash |
HIMS has more cash than debt.
IMMP Net Leverage
IMMP's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
HIMS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 36.0 | Neutral |
| Stochastic | 23.0 | Neutral |
HIMS's weekly RSI is 36 (neutral) and its Stochastic is 23 (neutral).
IMMP Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 28.0 | Oversold |
| Stochastic | 10.1 | Oversold |
IMMP's weekly RSI is 28 (oversold) and its Stochastic is 10 (oversold).
HIMS PE vs Healthcare Sector
| Metric | HIMS | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 26x | — |
HIMS has no meaningful PE right now: it lost money over the past year.
IMMP PE vs Healthcare Sector
IMMP has no meaningful PE right now: it lost money over the past year.
HIMS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $27.3 | 28% below |
| 20 week MA | $29.2 | 32% below |
| 50 week MA | $27.7 | 29% below |
| 100 week MA | $35.9 | 45% below |
| 200 week MA | $24.4 | 19% below |
HIMS is in a downtrend: it's below all five of its weekly moving averages, and 19% below its 200-week average.
IMMP Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.71 | 1.6% below |
| 20 week MA | $6.06 | 40% below |
| 50 week MA | $20.6 | 82% below |
| 100 week MA | $28.5 | 87% below |
| 200 week MA | $35.6 | 90% below |
IMMP is in a downtrend: it's below all five of its weekly moving averages, and 90% below its 200-week average.
HIMS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.89 | $15.0 | +51% |
| 2021 | $15.0 | $6.65 | -56% |
| 2022 | $6.65 | $6.43 | -3.3% |
| 2023 | $6.43 | $8.90 | +38% |
| 2024 | $8.90 | $26.6 | +198% |
| 2025 | $26.6 | $34.3 | +29% |
| 2026 YTD | $34.3 | $19.7 | -42% |
HIMS has the edge over IMMP on returns for 2026, with the stronger performance.
IMMP Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $117.4 | $58.8 | -50% |
| 2021 | $58.8 | $69.2 | +18% |
| 2022 | $69.2 | $40.0 | -42% |
| 2023 | $40.0 | $48.0 | +20% |
| 2024 | $48.0 | $40.2 | -16% |
| 2025 | $40.2 | $62.6 | +56% |
| 2026 YTD | $62.6 | $3.65 | -94% |
IMMP has finished lower in three of the last six years. It's down 94% so far in 2026.